243 related articles for article (PubMed ID: 16236815)
1. MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice.
Hechler B; Nonne C; Roh EJ; Cattaneo M; Cazenave JP; Lanza F; Jacobson KA; Gachet C
J Pharmacol Exp Ther; 2006 Feb; 316(2):556-63. PubMed ID: 16236815
[TBL] [Abstract][Full Text] [Related]
2. Antiaggregatory activity in human platelets of potent antagonists of the P2Y 1 receptor.
Cattaneo M; Lecchi A; Ohno M; Joshi BV; Besada P; Tchilibon S; Lombardi R; Bischofberger N; Harden TK; Jacobson KA
Biochem Pharmacol; 2004 Nov; 68(10):1995-2002. PubMed ID: 15476670
[TBL] [Abstract][Full Text] [Related]
3. Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500).
Ohlmann P; de Castro S; Brown GG; Gachet C; Jacobson KA; Harden TK
Pharmacol Res; 2010 Oct; 62(4):344-51. PubMed ID: 20594939
[TBL] [Abstract][Full Text] [Related]
4. [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.
Houston D; Ohno M; Nicholas RA; Jacobson KA; Harden TK
Br J Pharmacol; 2006 Mar; 147(5):459-67. PubMed ID: 16299552
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
Cattaneo M; Lecchi A
J Thromb Haemost; 2007 Mar; 5(3):577-82. PubMed ID: 17155953
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
7. Key role of the P2Y(1) receptor in tissue factor-induced thrombin-dependent acute thromboembolism: studies in P2Y(1)-knockout mice and mice treated with a P2Y(1) antagonist.
Léon C; Freund M; Ravanat C; Baurand A; Cazenave JP; Gachet C
Circulation; 2001 Feb; 103(5):718-23. PubMed ID: 11156884
[TBL] [Abstract][Full Text] [Related]
8. A platelet target for venous thrombosis? P2Y1 deletion or antagonism protects mice from vena cava thrombosis.
Bird JE; Wang X; Smith PL; Barbera F; Huang C; Schumacher WA
J Thromb Thrombolysis; 2012 Aug; 34(2):199-207. PubMed ID: 22588534
[TBL] [Abstract][Full Text] [Related]
9. 2-Chloro N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate is a selective high affinity P2Y(1) receptor antagonist.
Boyer JL; Adams M; Ravi RG; Jacobson KA; Harden TK
Br J Pharmacol; 2002 Apr; 135(8):2004-10. PubMed ID: 11959804
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition at adenine nucleotide (P2) receptors in platelets.
Jacobson KA; Mamedova L; Joshi BV; Besada P; Costanzi S
Semin Thromb Hemost; 2005 Apr; 31(2):205-16. PubMed ID: 15852224
[TBL] [Abstract][Full Text] [Related]
11. SAR216471, an alternative to the use of currently available P2Y₁₂ receptor inhibitors?
Delesque-Touchard N; Pflieger AM; Bonnet-Lignon S; Millet L; Salel V; Boldron C; Lassalle G; Herbert JM; Savi P; Bono F
Thromb Res; 2014 Sep; 134(3):693-703. PubMed ID: 25064036
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist.
Baurand A; Raboisson P; Freund M; Léon C; Cazenave JP; Bourguignon JJ; Gachet C
Eur J Pharmacol; 2001 Feb; 412(3):213-21. PubMed ID: 11166284
[TBL] [Abstract][Full Text] [Related]
13. The P2Y(1) receptor as a target for new antithrombotic drugs: a review of the P2Y(1) antagonist MRS-2179.
Baurand A; Gachet C
Cardiovasc Drug Rev; 2003; 21(1):67-76. PubMed ID: 12595918
[TBL] [Abstract][Full Text] [Related]
14. A novel P2Y(12) adenosine diphosphate receptor antagonist that inhibits platelet aggregation and thrombus formation in rat and dog models.
Wang YX; Vincelette J; da Cunha V; Martin-McNulty B; Mallari C; Fitch RM; Alexander S; Islam I; Buckman BO; Yuan S; Post JM; Subramanyam B; Vergona R; Sullivan ME; Dole WP; Morser J; Bryant J
Thromb Haemost; 2007 May; 97(5):847-55. PubMed ID: 17479197
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
Gremmel T; Yanachkov IB; Yanachkova MI; Wright GE; Wider J; Undyala VV; Michelson AD; Frelinger AL; Przyklenk K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):501-9. PubMed ID: 26743169
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].
Hechler B; Magnenat S; Zighetti ML; Kassack MU; Ullmann H; Cazenave JP; Evans R; Cattaneo M; Gachet C
J Pharmacol Exp Ther; 2005 Jul; 314(1):232-43. PubMed ID: 15792995
[TBL] [Abstract][Full Text] [Related]
17. The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys.
Wong PC; Watson C; Crain EJ
J Thromb Thrombolysis; 2016 Apr; 41(3):514-21. PubMed ID: 26660522
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
Nandanan E; Jang SY; Moro S; Kim HO; Siddiqui MA; Russ P; Marquez VE; Busson R; Herdewijn P; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2000 Mar; 43(5):829-42. PubMed ID: 10715151
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Savi P; Herbert JM
Semin Thromb Hemost; 2005 Apr; 31(2):174-83. PubMed ID: 15852221
[TBL] [Abstract][Full Text] [Related]
20. Novel antagonists acting at the P2Y(1) purinergic receptor: synthesis and conformational analysis using potentiometric and nuclear magnetic resonance titration techniques.
Raboisson P; Baurand A; Cazenave JP; Gachet C; Retat M; Spiess B; Bourguignon JJ
J Med Chem; 2002 Feb; 45(4):962-72. PubMed ID: 11831909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
